Viewing Study NCT00064233


Ignite Creation Date: 2025-12-25 @ 2:43 AM
Ignite Modification Date: 2025-12-27 @ 11:33 PM
Study NCT ID: NCT00064233
Status: COMPLETED
Last Update Posted: 2020-08-03
First Post: 2003-07-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate
Sponsor: Jonsson Comprehensive Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module